ZS

Zeeshan Siddiqui

Active Director Director DIN 09708759
DIN 09708759 First appointment Aug 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Zeeshan Siddiqui

Data last updated:

Zeeshan Siddiqui is a Director at Apstus Ayurveda Private Limited (since 2022). The company operates in Chemicals.

DIN 09708759
Primary Designation Director
Industry Chemicals
First Appointment 19 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apstus Ayurveda Private Limited U24290UP2022PTC169207
Director19 Aug 20222022Active

Board colleagues of Zeeshan Siddiqui

NameDINCompanyDesignation
Neha Mishra08664459Apstus Ayurveda Private LimitedAdditional Director
Shabina Bano08246096Apstus Ayurveda Private LimitedDirector

Directorship timeline

Open interactive timeline →
Apstus Ayurveda Private Limited
Premium access

Shareholding and investment profile for Zeeshan Siddiqui

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zeeshan Siddiqui

Zeeshan Siddiqui currently holds 1 directorship: Apstus Ayurveda Private Limited (Director, since 19 Aug 2022).

Zeeshan Siddiqui was first appointed on 19 Aug 2022 as Director at Apstus Ayurveda Private Limited.

The current boards of Zeeshan Siddiqui's companies include Neha Mishra (Apstus Ayurveda Private Limited), Shabina Bano (Apstus Ayurveda Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available